Weiss Multi-Strategy Advisers’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23,409	Closed	-$1.46M	–	521
2023 Q4	$1.46M	Buy	+23,409	New	+$582K	0.04%	402

Weiss Multi-Strategy Advisers's RYZB Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 23,409 shares — an estimated $1.46M sold.

Weiss Multi-Strategy Advisers first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $1.46M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 23,409 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $1.46M.
Weiss Multi-Strategy Advisers first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Weiss Multi-Strategy Advisers's RayzeBio, Inc. Common Stock position peaked at $1.46M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.